Regardless of how hard Stassi's owner tried to tempt her out of the car, nothing was going to make her move from the passenger seat.

Chardan Capital reaffirmed their buy rating on shares of SAB Biotherapeutics (NASDAQ:SABS – Free Report) in a research report report published on Thursday,Benzinga reports. Chardan Capital currently ...

$SABS ($SABS) is expected to release its quarterly earnings data on Monday, May 19th before market open, per Finnhub. Analysts are expecting revenue of $170,003 and ...

Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Financials, Technology and Consumer Services ...

Stock splits are a good signal from management that a stock's strong price performance is justified and can continue. This company has consistently executed a playbook that's turned it into a ...

THE SA Bureau of Standards (SABS) has defended itself as the entity faces an independent investigation into its affairs. The probe is expected to be completed at the end of next month. Trade ...

SABS stock touches 52-week low at $1.45 amid market challenges Open in App Get 45% Off Sign In Free Sign Up ...